ROMA Risk of Ovarian Malignancy Algorithm Test
Comprehensive Ovarian Cancer Risk Assessment
The ROMA (Risk of Ovarian Malignancy Algorithm) Test represents a significant advancement in ovarian cancer screening and risk assessment. This sophisticated diagnostic tool combines multiple biomarkers with clinical data to provide a comprehensive evaluation of ovarian cancer risk, offering women and their healthcare providers valuable insights for early detection and management strategies.
What the ROMA Test Measures
The ROMA test utilizes a sophisticated algorithm that integrates three critical components:
- CA125 Biomarker: Measures cancer antigen 125 levels, a protein often elevated in ovarian cancer
- HE4 Biomarker: Assesses human epididymis protein 4, a newer biomarker with high specificity for ovarian cancer
- Menopausal Status: Incorporates patient’s menopausal status to refine risk calculation accuracy
Who Should Consider the ROMA Test
This test is particularly recommended for women experiencing:
- Persistent abdominal bloating or discomfort
- Pelvic or abdominal pain
- Difficulty eating or feeling full quickly
- Urinary symptoms including urgency or frequency
- Unexplained weight loss or fatigue
- Family history of ovarian or breast cancer
- Presence of pelvic masses detected during examination
- Concerns about genetic predisposition to ovarian cancer
Key Benefits of ROMA Testing
- Early Detection: Identifies potential ovarian malignancies at earlier, more treatable stages
- Risk Stratification: Provides personalized risk assessment based on multiple factors
- Improved Accuracy: Combines multiple biomarkers for enhanced diagnostic precision
- Clinical Guidance: Helps physicians make informed decisions about further testing or treatment
- Peace of Mind: Offers reassurance for women concerned about ovarian cancer risk
- Proactive Health Management: Enables early intervention and monitoring strategies
Understanding Your ROMA Test Results
Your ROMA test results will provide a calculated risk score that helps categorize your likelihood of having ovarian cancer:
- Low Risk: Indicates minimal likelihood of ovarian malignancy
- High Risk: Suggests increased probability requiring further evaluation
- Biomarker Levels: Individual CA125 and HE4 values with reference ranges
- Clinical Correlation: Results should always be interpreted by your healthcare provider in context of your overall health
Test Pricing Information
| Test Name | Discount Price | Regular Price |
|---|---|---|
| ROMA Risk of Ovarian Malignancy Algorithm Test | $112 USD | $188 USD |
Nationwide Testing Availability
GGC DNA provides comprehensive ROMA testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure accurate and timely results using the advanced Chemiluminescent Microparticle Immunoassay method.
Take Control of Your Ovarian Health Today
Don’t wait to address concerns about ovarian cancer risk. The ROMA test offers a scientifically validated approach to early detection and risk assessment. With same-day reporting available when samples are submitted by 4 pm on Monday or Thursday, you can receive timely results to guide your healthcare decisions.
Book your ROMA Risk of Ovarian Malignancy Algorithm Test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment online. Take the first step toward proactive ovarian health management with GGC DNA’s comprehensive testing services.
